CDSCO releases Form for reporting Medical Devices Adverse Event ; designed to be used voluntarily by Manufacturer / Importer / Distributor of Medical Devices, Healthcare Professionals having knowledge of such adverse events by Lexplosion | Jun 11, 2019 | Healthcare, OPS, Pharmaceuticals, statesThe Central Drugs Standard Control Organization has, recently released a Form for... Read More
CDSCO issues a list of spurious, adulterated, misbranded, or not of standard quality drugs and devices for the month of April, 2019 by Lexplosion | May 16, 2019 | OPS, Pharmaceuticals, statesThe Central Drugs Standard Control Organization (“CDSCO”) in their official website has published... Read More
CDSCO directs applicants to upload applications through SUGAM Portal as per the New Drugs and Clinical Trial Rules, 2019 by Lexplosion | Apr 13, 2019 | OPS, Pharmaceuticals, statesThe Central Drugs Standard Control Organization, 2019 has released a circular dated 10th April,... Read More
Ministry of Health and Family Welfare has added ‘organ preservative solution’ as a drug under Drugs and Cosmetics Act, 1940 by Lexplosion | Apr 4, 2019 | OPS, Pharmaceuticals, statesThe Ministry of Health and Family Welfare, in a recent notification dated 2nd April, 2019 has... Read More
Ministry of Health and Family Welfare notifies New Drugs and Clinical Trials Rules, 2019; effective 19th March, 2019 by Lexplosion | Mar 28, 2019 | PharmaceuticalsThis is a quick update to let you all know that the Ministry of Health and Family Welfare, has... Read More
Department of Biotechnology proposes the first ever ‘Guidelines for Evaluating Nanopharmaceuticals’; it is expected to ensure quality / safety / efficacy of use nanotechnology in the pharmaceuticals industry by Lexplosion | Mar 25, 2019 | OPS, Pharmaceuticals, statesDepartment of Biotechnology, Government of India and Indian Society of Nanomedicine have jointly... Read More
